Raqia Therapeutics
Raqia Therapeutics is a biotechnology company developing on a revolutionary immunotherapy technique called chimeric antigen receptors.
Raqia Therapeutics is active in the biotechnology, health care, therapeutics space based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2020.
Within the biotechnology, health care, therapeutics space, the company focuses on its core offering rather than a broad product line.
Its base of operations is Greater Boston Area, East Coast, New England, Northeastern US.
The company is listed at the Private company stage of development.
Its team size is recorded as c_00001_00010 employees.
| Sector | Biotechnology, Health Care, Therapeutics |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Founded | 2020 |
| Employees | c_00001_00010 |
| Stage | Private company |
Website: www.raqiatx.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account